cylophosphamide in neuropsychiatric sle

CYLOPHOSPHAMIDE IN NEUROPSYCHIATRIC SLE

ALGORITMA PENATALAKSANAAN SLE

Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia

Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia

Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia

Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia

Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia

– Cyclophosphamide given as monthly intravenous (500–1000mg/m2) doses for a six

month induction period followed by quarterly maintenance doses for a period of

two years

– Cyclophosphamide is a cytotoxic immunosuppressive treatment option with

documented therapeutic benefits in the management of severe NPSLE manifestations

unresponsive to other treatment modalities (nephritis and CNS manifestations)

Muscal, E & Brey, RL. 2011. Neurological Manifestations of Systemic Lupus Erythematosus in Children and Adults. NIH Public Access. Published in final edited form as:Neurol Clin. 2010 February

DAPUS

• Muscal, E & Brey, RL. 2011. Neurological Manifestations of Systemic Lupus Erythematosus in Children and Adults. NIH Public Access. Published in final edited form as: Neurol Clin. 2010 February

• Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia